Reproductive Biology and Endocrinology 2011, 9:89 Foidart JM, Colin C, Denoo X, et al
In SPCD, a genetic mutation prevents your body from holding onto carnitine, causing levels in your blood and tissues to drop dangerously low [6] [1]
Liraglutide, a GLP-1 receptor agonist (GLP-1RA), was shown to reduce serum total cholesterol, LDL-C, high-density lipoprotein cholesterol (HDL-C), and TG levels by decreasing hepatic LDLR and PCSK9 expression in db/db mice, but not in wild-type mice [16]
Childs BG, Durik M, Baker DJ, van Deursen JM (2015) Cellular senescence in aging and age-related disease: from mechanisms to therapy
While side effects are rare, being mindful of how you feel after each treatment helps us fine-tune your wellness plan
Both platforms support patients for as long as clinically appropriate, with most patients continuing therapy for 12-24 months or longer